Background: Treatment strategies for patients with malignant pleural mesothelioma (MPM) include pneumectomy followed by radiation with considerable efficacy, although post-surgical morbidity and mortality are frequent. Recently, more conservative surgical approaches have been implemented, including Pleurectomy/Decortication (P/D), which spares the lung tissue while removing the malignant pleura and visible tumor. Although this approach significantly reduces surgical morbidity, it poses a challenge for post-surgical radiotherapy, as the risk of developing radiation pneumonitis is high. In this feasibility study we evaluated the loco-regional control and toxicity profile in patients with MPM treated with induction chemotherapy followed by P/C and Intensity Modulated Radiotherapy (IMRT) to the entire thoracic cavity. Method: Patients with MPM treated from October 2011 to February 2014 were screened for inclusion. All patients underwent 4 cycles of induction chemotherapy with cisplatin/gemcitabine or cisplatin/ pemetrexed without progression followed by P/D. Thereafter, patients received IMRT to the thoracic cavity (50.4-54 Gy in 28-30 fractions), treated with 9-11 non-coplanar fields. Result: A total of 20 patients were screened for inclusion, from these, 13 patients were included in the final analysis. The median age was 61.3 ±10.3 years; 69.2% (9/13) were classified as low risk according to the European Organization for Research and Treatment of Cancer prognostic group. From the 13 patients, 12 (92.3%) had a histological diagnosis of epithelioid mesothelioma, while one patient (7.7%) presented with a sarcomatoid histology. Partial response to chemotherapy was observed in 61.5% (8/13) and stable disease in 38.5% (5/13). After P/D, only 23% (3/13) had residual macroscopic disease. The median follow-up was 23.6 months (7.5-44.7). Nine patients had recurrence or progression (6 distant [67%] and 3 loco-regional recurrences [33%]). 2-year Progression Free Survival was 31. ). Only one patient died due to hepatic metastases. Any grade Pneumonitis was reported in 69.2% (9/ 13), however only 22.2% (n¼2) of patients presented grade 3 pneumonitis. The V5 of the contralateral lung was above 70% and the V20 of the total lung was 45% in these patients. No IMRTrelated deaths were observed throughout the study. Conclusion: Results from this pilot study show that it is feasible to administer IMRT to patients who have undergone P/D while maintaining an adequate toxicity profile. In our study pulmonary toxicity was frequent; however there was only one event of grade 4 pneumonitis, meanwhile the loco-regional control using this treatment modality shows great promise. However, a larger study with a more robust sample size is required to draw strong conclusions.
Background: The associated morbidity from radical surgery implies that it should only be offered to those with the best prognosis. The prognosis following radical surgery for mesothelioma is significantly influenced by the presence of pathological nodal metastases. However, the prediction of nodal positivity is inaccurate and complicated. This can be attributed to the unique lymphatic drainage pattern in which many nodal groups (internal mammary, intercostal) cannot be biopsied preoperatively. Previous studies have correlated preclinical variables with poor prognosis (Pass, J Thorac Oncol.2014; 9:856-64) . Method: We have correlated clinical variables known to be associated with overall prognosis in mesothelioma with the pathological findings of systematic nodal dissection at thoracotomy and pleurectomy/decortication. The variables analysed: patient demographics, Haemoglobin and CRP, T and N stage on preoperative CT scan, duration of symptoms of weight loss and chest pain and cell type on preoperative biopsy. Data were summarised as median (range), mean (SD) and subject to Chi-squared test for the categorical data and Mann-Whitney Test for the numeric data and to regression analysis. Result: 32 patients(25males:7females)underwent extended pleurectomy decortication with intraoperative systematic nodal dissection. On pathologic diagnosis post-resection, 20(62%) patients were diagnosed with nodal metastasis. On univariate analysis, only age and CRP was statistically significant (p¼0.049,respectively 0.05). The remaining variables did not achieve statistical significance. There were statistical trends suggesting that nodal positivity was more likely in the younger males with a lower Haemoglobin and a raised CRP. CT correctly predicted positive node status in 30% of cases and negative node status in 80% of cases. Conclusion: Nodal positivity in patients suitable for EPD cannot be reliably predicted by CT but can be inferred from certain clinical variables. Future work in a larger population is required to identify a definitive pre-operative model. This will allow for better selection of patients for primary surgical intervention or alternatively for induction chemotherapy. 
